# Phibro Animal Health (PAHC) — Earnings

PAHC · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/pahc/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q4 2026 |
| Period end | Jun 30, 2026 |
| EPS actual | $0.85 |
| EPS estimate | $0.71 |
| EPS surprise | +19.25% |
| Revenue surprise | +4.07% |
| Revenue | $396.7M |
| Revenue estimate | $381.2M |
| Reported | Aug 26, 2026 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/1069899/000110465926101493/pahc-20260630x10k.htm) |
| Earnings call | [Transcript](http://o.thsi.cn/dc-d-stock-america.teleconference/f0b4e957-aca1-b41c-decc-ba5d9cd6cbe2.html) |

Phibro Animal Health reported fiscal Q4 2026 results on August 26, 2026. Earnings per share were $0.85, ahead of the $0.71 estimate by 19.25%. Revenue of $396.7 million beat the $381.2 million consensus by 4.07%. Compared with fiscal Q4 2025, EPS rose about 49% from $0.57 and revenue rose about 5% from $378.7 million.

Fiscal 2026 was the strongest year in the table. Annual EPS reached $3.21, up about 54% from $2.09 in fiscal 2025, which itself was up about 76% from $1.19 in fiscal 2024. Fiscal 2022 to 2024 held between $1.19 and $1.31. Revenue rose from $1.02 billion in fiscal 2024 to $1.30 billion in fiscal 2025 and $1.52 billion in fiscal 2026. Q4 2026 revenue was the highest quarter here, and Q2 2026 EPS of $0.87 the highest per-share figure. Phibro beat the EPS estimate in each of the last eight quarters and in 14 of the last 20.

Fiscal Q1 results came between November 2 and November 9 in each of the past five years. That points to early November 2026 for the next report, the first of fiscal 2027. It will show whether the year-over-year growth of fiscal 2026 carries into the new year.

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q4 2026 | Aug 26, 2026 | $0.71 | $0.85 | 19.25% | $381.2M | $396.7M |
| Q3 2026 | May 6, 2026 | $0.71 | $0.76 | 6.59% | $367.0M | $383.5M |
| Q2 2026 | Feb 4, 2026 | $0.67 | $0.87 | 29.85% | $355.6M | $373.9M |
| Q1 2026 | Nov 5, 2025 | $0.62 | $0.73 | 17.27% | $347.0M | $363.9M |
| Q4 2025 | Aug 27, 2025 | $0.52 | $0.57 | 9.34% | $362.4M | $378.7M |
| Q3 2025 | May 7, 2025 | $0.52 | $0.63 | 21.04% | $352.2M | $347.8M |
| Q2 2025 | Feb 5, 2025 | $0.43 | $0.54 | 27.06% | $292.3M | $309.3M |
| Q1 2025 | Nov 6, 2024 | $0.25 | $0.35 | 41.13% | $246.7M | $260.4M |
| Q4 2024 | Aug 28, 2024 | $0.33 | $0.41 | 23.01% | $260.5M | $273.2M |
| Q3 2024 | May 8, 2024 | $0.29 | $0.31 | 6.90% | $253.6M | $263.2M |
| Q2 2024 | Feb 7, 2024 | $0.28 | $0.33 | 17.86% | $240.9M | $249.9M |
| Q1 2024 | Nov 8, 2023 | $0.23 | $0.14 | -39.13% | $242.0M | $231.3M |
| Q4 2023 | Aug 30, 2023 | $0.37 | $0.38 | 2.01% | $256.1M | $255.0M |
| Q3 2023 | May 3, 2023 | $0.34 | $0.29 | -13.43% | $246.7M | $245.7M |
| Q2 2023 | Feb 8, 2023 | $0.30 | $0.34 | 12.40% | $241.3M | $244.6M |
| Q1 2023 | Nov 9, 2022 | $0.26 | $0.21 | -20.24% | $232.1M | $232.5M |
| Q4 2022 | Aug 24, 2022 | $0.38 | $0.36 | -4.43% | $250.0M | $255.3M |
| Q3 2022 | May 4, 2022 | $0.35 | $0.33 | -6.59% | $230.5M | $239.6M |
| Q2 2022 | Feb 9, 2022 | $0.33 | $0.37 | 12.91% | $215.3M | $232.7M |
| Q1 2022 | Nov 2, 2021 | $0.29 | $0.25 | -14.76% | $201.1M | $214.7M |

## Frequently Asked Questions

### When did Phibro Animal Health (PAHC) last report earnings?

Phibro Animal Health last reported on Aug 26, 2026, covering fiscal Q4 2026.

### Did PAHC beat earnings estimates?

Yes. Phibro Animal Health reported EPS of $0.85 for Q4 2026 against a $0.71 estimate — a 19.25% beat.

### How much revenue did PAHC report last quarter?

Phibro Animal Health reported $396.7M in revenue for Q4 2026, against a consensus estimate of $381.2M.

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).